Zymeworks INC. (ZYME) — 8-K Filings

All 8-K filings from Zymeworks INC.. Browse 26 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (26)

Zymeworks Inc. Files 8-K: Officer/Director Changes & Compensation — Apr 1, 2026 Risk: medium
On April 1, 2026, Zymeworks Inc. filed an 8-K report detailing the departure of certain officers and directors, as well as compensatory arrangements. The filing
8-K Filing — Dec 30, 2025
Zymeworks Inc. Announces Corporate Changes and Filings — Nov 18, 2025 Risk: medium
Zymeworks Inc. announced on November 16, 2025, a series of significant corporate events. These include the departure of directors, the election of new directors
Zymeworks Inc. Files 8-K Report — Nov 17, 2025 Risk: low
On November 17, 2025, Zymeworks Inc. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits, with no specific materia
Zymeworks Inc. Files 8-K Report — Sep 2, 2025 Risk: low
On September 2, 2025, Zymeworks Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with a Regulation FD disclosure
Zymeworks Inc. Files 8-K: Agreements, Equity Sales, Officer Changes — Aug 11, 2025 Risk: medium
On August 9, 2025, Zymeworks Inc. filed an 8-K report detailing several key events. These include the entry into a material definitive agreement, unregistered s
Zymeworks Inc. Files 8-K: Material Agreement, Equity Sales — Jun 27, 2025 Risk: medium
On June 26, 2025, Zymeworks Inc. filed an 8-K report detailing an entry into a material definitive agreement. The filing also covers unregistered sales of equit
Zymeworks Inc. Files 8-K with Financials and Other Events — May 30, 2025 Risk: low
Zymeworks Inc. filed an 8-K on May 30, 2025, reporting on various events. The filing includes information related to financial statements and exhibits, as well
Zymeworks Inc. Announces Board and Officer Changes — Feb 18, 2025 Risk: medium
Zymeworks Inc. announced on February 17, 2025, a change in its board of directors and executive officers. The filing details the departure of certain directors
Zymeworks Inc. Files 8-K on Operations and Financials — Jan 8, 2025 Risk: low
Zymeworks Inc. filed an 8-K on January 8, 2025, reporting on its results of operations, other events, and financial statements. The filing details the company's
Zymeworks Inc. Shareholder Meeting Results Announced — Dec 11, 2024 Risk: low
On December 10, 2024, Zymeworks Inc. announced the results of its annual general meeting of shareholders. Shareholders voted to elect the nominated directors, a
Zymeworks Inc. Files 8-K Report — Nov 21, 2024 Risk: low
On November 21, 2024, Zymeworks Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a Regulat
Zymeworks Inc. Announces Board Changes — Oct 18, 2024 Risk: low
On October 15, 2024, Zymeworks Inc. reported the departure of Director Dr. Paul Hastings and the appointment of Dr. Steven M. Altschuler as a new director. The
Zymeworks Inc. Appoints New Directors, Adjusts Executive Compensation — Sep 3, 2024 Risk: medium
Zymeworks Inc. announced on August 30, 2024, changes in its board of directors and executive compensation. Specifically, the company elected two new directors,
Zymeworks Inc. Files Material Definitive Agreement 8-K — Aug 2, 2024 Risk: medium
On August 2, 2024, Zymeworks Inc. filed an 8-K report detailing a material definitive agreement. The filing does not provide specific details about the agreemen
Zymeworks Inc. Files 8-K Report — Aug 1, 2024 Risk: low
On August 1, 2024, Zymeworks Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a Regulation
Zymeworks Inc. Announces Director Changes and Officer Compensation Details — Jul 25, 2024 Risk: medium
On July 19, 2024, Zymeworks Inc. filed an 8-K report detailing the departure of Director Dr. Paul Hastings and the appointment of Dr. Steven A. Rosenberg as a n
Zymeworks Inc. Files 8-K Report — Jun 10, 2024 Risk: low
On June 10, 2024, Zymeworks Inc. filed an 8-K report. The filing indicates that the company is providing information under "Other Events." Specific details rega
Zymeworks Appoints New Chief Medical Officer — May 3, 2024 Risk: medium
On May 3, 2024, Zymeworks Inc. filed an 8-K report detailing the appointment of Dr. Paul W. Smith as Chief Medical Officer, effective May 6, 2024. Dr. Smith bri
Zymeworks Inc. Files 8-K: Board & Officer Changes — Apr 4, 2024 Risk: medium
On April 3, 2024, Zymeworks Inc. filed an 8-K report detailing changes in its board of directors and executive officers. The filing includes information on the
Zymeworks Inc. Reports Board and Executive Compensation Changes — Apr 1, 2024 Risk: medium
On March 31, 2024, Zymeworks Inc. reported changes in its board of directors and executive compensation arrangements. The filing details the departure of certai
Zymeworks Inc. Announces Director Changes and Officer Compensation — Mar 28, 2024 Risk: low
On March 27, 2024, Zymeworks Inc. filed an 8-K report detailing the departure of Director Dr. Paul Hastings and the appointment of Dr. Steven A. Rosenberg as a
Zymeworks Reports Executive/Board Changes and Compensation Arrangements — Feb 22, 2024 Risk: medium
Zymeworks Inc. filed an 8-K on February 22, 2024, to report an event related to the departure or election of directors or officers, and compensatory arrangement
Zymeworks Reports Executive/Director Changes on Feb 6 — Feb 8, 2024 Risk: medium
Zymeworks Inc. filed an 8-K on February 8, 2024, reporting an event that occurred on February 6, 2024. This filing indicates a change in the company's executive
Zymeworks 8-K: Executive/Director Changes or Compensation Update — Jan 5, 2024
Zymeworks Inc. filed an 8-K on January 5, 2024, reporting an event that occurred on January 3, 2024. This filing indicates a change in the company's executive o
Zymeworks Files 8-K on Operations & Financial Condition — Jan 4, 2024
Zymeworks Inc. filed an 8-K on January 4, 2024, to report on its 'Results of Operations and Financial Condition' and 'Other Events.' This filing indicates that

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX